Suven Pharmaceuticals Limited (SUVENPHAR.NS)
INR 1184.8
(3.06%)
INR 1184.8
(3.06%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 11.80 INR | -26.98% |
| 2022 | 16.16 INR | -9.37% |
| 2021 | 17.83 INR | 25.3% |
| 2020 | 14.23 INR | 128.41% |
| 2019 | 6.23 INR | 45.22% |
| 2018 | 4.29 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 2.39 INR | 13.81% |
| 2023 Q4 | 2.10 INR | 14.13% |
| 2023 Q3 | 1.84 INR | -41.21% |
| 2023 Q1 | 4.74 INR | -2.67% |
| 2023 Q2 | 3.13 INR | -33.97% |
| 2023 FY | - INR | -26.98% |
| 2022 Q1 | 4.22 INR | 17.22% |
| 2022 Q4 | 4.87 INR | 15.13% |
| 2022 Q3 | 4.23 INR | 49.47% |
| 2022 Q2 | 2.83 INR | -32.94% |
| 2022 FY | - INR | -9.37% |
| 2021 Q1 | 4.13 INR | 26.69% |
| 2021 Q2 | 3.81 INR | -7.75% |
| 2021 Q4 | 3.60 INR | -42.77% |
| 2021 Q3 | 6.29 INR | 65.09% |
| 2021 FY | - INR | 25.3% |
| 2020 Q3 | 4.46 INR | 53.26% |
| 2020 FY | - INR | 128.41% |
| 2020 Q2 | 2.91 INR | -19.17% |
| 2020 Q1 | 3.60 INR | 23.71% |
| 2020 Q4 | 3.26 INR | -26.91% |
| 2019 Q3 | 2.27 INR | -37.81% |
| 2019 Q4 | 2.91 INR | 28.19% |
| 2019 FY | - INR | 45.22% |
| 2019 Q2 | 3.65 INR | 1.11% |
| 2019 Q1 | 3.61 INR | 22.79% |
| 2018 Q3 | 1.35 INR | 0.0% |
| 2018 Q4 | 2.94 INR | 117.78% |
| 2018 FY | - INR | 0.0% |